- JP-listed companies
- Chiome Bioscience Inc.
- Income statement
Chiome Bioscience Inc.【JP:4583】Income statement
Market cap
¥7.4B
P/E ratio
| 2011/03 | 2012/03 | 2013/03 | 2014/03 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 463 | 633 | 324 | 413 | 186 | 280 | 252 | 260 | 213 | 448 | 481 | 713 | 631 | 682 | 781 | 593 |
| Revenue growth (%) | - | |||||||||||||||
| Cost of revenue | - | - | - | - | 89 | 138 | 138 | 85 | 102 | 163 | 236 | 290 | 282 | 284 | 348 | 238 |
| Gross profit | - | - | - | - | 97 | 142 | 114 | 174 | 111 | 285 | 245 | 422 | 349 | 399 | 433 | 356 |
| Gross margin (%) | - | - | - | - | ||||||||||||
| Operating margin (%) | - | - | - | - | ||||||||||||
| Operating expenses | - | - | - | - | 918 | 1,412 | 1,157 | 1,062 | 1,650 | 1,687 | 1,529 | 1,757 | 1,608 | 1,604 | 1,464 | 1,335 |
| Operating income | - | - | - | - | -820 | -1,270 | -1,042 | -888 | -1,539 | -1,402 | -1,284 | -1,334 | -1,259 | -1,205 | -1,031 | -979 |
| Income before tax | -237 | -43 | -425 | -706 | -838 | -1,254 | -1,047 | -884 | -1,534 | -1,410 | -1,292 | -1,329 | -1,244 | -1,217 | -1,019 | -989 |
| Pretax margin (%) | -51.3 | -6.8 | -131.1 | -171.2 | -449.4 | -447.6 | -415.2 | -340 | -720.7 | -315.1 | -268.6 | -186.5 | -197.2 | -178.4 | -130.5 | -166.7 |
| Provision for income taxes | - | - | - | - | 0 | 2 | -10 | 2 | 2 | 2 | 3 | 13 | 5 | 5 | 3 | 3 |
| Effective tax rate (%) | - | - | - | - | ||||||||||||
| Net income | -180 | -44 | -427 | -748 | -885 | -1,283 | -1,491 | -883 | -1,534 | -1,404 | -1,294 | -1,480 | -1,243 | -1,220 | -1,021 | -982 |
| Earnings per share | -15.85 | -3.03 | -25.48 | -39.12 | -43.45 | -58.29 | -65.91 | -33.48 | -57.26 | -44.61 | -36.06 | -36.74 | -28.26 | -24.62 | -17.54 | -14.47 |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |